Amit Pradeep Nayak

Insider activity · 24 months1 buy1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 1 buy · 1 saleFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 23 Jan 2026 for JB Chemicals & Pharmaceuticals Limited, €207k.

Filing timeline

BuySale

Amit Pradeep Nayak

Amit Pradeep Nayak: trading record in brief

Amit Pradeep Nayak is a declared insider of JB Chemicals & Pharmaceuticals Limited, with filings sourced from SEBI (PIT + SAST). We count 5 filings; the first trade dates from 22 August 2025 and the latest from 23 January 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 23 January 2026, reports a transaction of €207k in JB Chemicals & Pharmaceuticals Limited. Most trades are made public on the day they happen. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.